National trends in the recommendation of radiotherapy after prostatectomy for prostate cancer before and after the reporting of a survival benefit in March 2009

Clinical Genitourinary Cancer

Volumn 13, Issue 3, 2015, Pages e167-e172

  Mahal, Brandon A ^a   Hoffman, Karen E ^b   Efstathiou, Jason A ^a   Nguyen, Paul L ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adjuvant; Prostatectomy; Prostatic Neoplasm; Radiation Therapy; Randomized Control Trial

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTPROSTATECTOMY RADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; PROSTATE CANCER; PROSTATECTOMY; ADJUVANT RADIOTHERAPY; CANCER REGISTRY; COHORT ANALYSIS; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84929073183     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2014.12.005     Document Type: Article

References (30)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
2. T.J. Wilt, M.K. Brawer, and K.M. Jones et al. Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
3. A. Bill-Axelson, L. Holmberg, and M. Ruutu et al. Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708 1717
4. M.R. Cooperberg, J.M. Broering, and M.S. Litwin et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry J Urol 171 2004 1393 1401
5. S.R. Bott, A.A. Freeman, S. Stenning, J. Cohen, and M.C. Parkinson Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time BJU Int 95 2005 34 39
6. J.F. Ward, H. Zincke, E.J. Bergstralh, J.M. Slezak, R.P. Myers, and M.L. Blute The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy J Urol 172 2004 1328 1332
7. I.M. Thompson, C.M. Tangen, and J. Paradelo et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial J Urol 181 2009 956 962
8. T. Wiegel, D. Bartkowiak, and D. Bottke et al. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial Eur Urol 66 2014 243 250
9. M. Bolla, H. van Poppel, and B. Tombal et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) Lancet 380 2012 2018 2027
10. M. Bolla, H. van Poppel, and L. Collette et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
11. I.M. Thompson Jr., C.M. Tangen, and J. Paradelo et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335
12. T. Wiegel, D. Bottke, and U. Steiner et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
13. K.E. Hoffman, P.L. Nguyen, and M.H. Chen et al. Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials J Urol 185 2011 116 120
14. N.C. Sheets, L.H. Hendrix, I.M. Allen, and R.C. Chen Trends in the use of postprostatectomy therapies for patients with prostate cancer: a surveillance, epidemiology, and end results Medicare analysis Cancer 119 2013 3295 3301
15. National Cancer Institute. SEER Cancer Statistics Review, 1975-2010, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Available at: http://seer.cancer.gov/csr/1975-2010/. Accessed May 21, 2014.
16. Surveillance, Epidemiology, and End Results (SEER) Program: Research Data (1973-2011), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, based on November 2013 SEER data submission, posted to the SEER web site, April 2014. Available at: http://seer.cancer.gov/data/seerstat/nov2013/. Accessed May 21, 2014.
17. Appendix C: Site Specific Coding Modules. 2012 SEER Coding and Staging Manual. Available at: http://seer.cancer.gov/archive/manuals/2012/appendixc.html. Accessed May 1, 2014.
18. United States Census Bureau. Census 2000 Gateway. Available at: http://www.census.gov/main/www/cen2000.html. Accessed December 27, 2013.
19. United States Department of Agriculture Rural-Urban Continuum Codes. Available at: http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx. Accessed December 27, 2013.
20. Joinpoint Regression Program, Version 4.1.0-April 2014; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute. Available at: http://surveillance.cancer.gov/joinpoint/. Accessed May 21, 2014.
21. H.J. Kim, M.P. Fay, E.J. Feuer, and D.N. Midthune Permutation tests for joinpoint regression with applications to cancer rates Stat Med 19 2000 335 351
22. Radiotherapy and androgen deprivation in combination after local surgery: a randomised controlled trial in prostate cancer. Available at: http://www.radicals-trial.org/. Accessed May 29, 2014.
23. ClinicalTrials.gov [Web site]. Radiotherapy - Adjuvant Versus Early Salvage (RAVES). Available at: http://clinicaltrials.gov/show/NCT00860652. Accessed May 29, 2014.
24. J.A. Efstathiou Postoperative radiation for prostate cancer Lancet 380 2012 1974 1976
25. S.P. Kim, J.C. Tilburt, and R.J. Karnes et al. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty Urology 82 2013 807 812
26. T.N. Showalter, N. Ohri, and K.G. Teti et al. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy Int J Radiat Oncol Biol Phys 82 2012 e233 e238
27. R.S. Punglia, J.C. Weeks, B.A. Neville, and C.C. Earle Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information J Clin Oncol 24 2006 3474 3482
28. N.G. Coburn, U. Guller, and N.N. Baxter et al. Adjuvant therapy for resected gastric cancer-rapid, yet incomplete adoption following results of intergroup 0116 trial Int J Radiat Oncol Biol Phys 70 2008 1073 1080
29. Aboagye JK, Kaiser HE, Hayanga AJ. Rural-urban differences in access to specialist providers of colorectal cancer care in the united states: a physician workforce issue. JAMA Surg, Published online Apr 16, 2014; http://dx.doi.org/10.1001/jamasurg.2013.5062.
30. L.M. Baldwin, C.H. Andrilla, M.P. Porter, R.A. Rosenblatt, S. Patel, and M.P. Doescher Treatment of early-stage prostate cancer among rural and urban patients Cancer 119 2013 3067 3075